In late 2021, she started on the diabetes drug Ozempic. Within months, she was able to stop taking the short-acting insulin she typically took before each meal altogether, and she has substantially reduced the dose of long-acting insulin she uses daily.
But in recent years, Ozempic and a similar drug, Mounjaro both weekly shots that can lower blood sugar, in part by mimicking a hormone that stimulates insulin production have offered patients an enticing new option to try managing their Type 2 diabetes without relying as heavily on insulin.
[
add
]
[
|
|
...
]